Federation des caisses Desjardins du Quebec’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-170	Closed	-$2.69K	–	2210
2018 Q2	$2.69K	Hold	170	–	–	﹤0.01%	1986
2018 Q1	$2.92K	Hold	170	–	–	﹤0.01%	1959
2017 Q4	$3.73K	Hold	170	–	–	﹤0.01%	1926
2017 Q3	$6.96K	Hold	170	–	–	﹤0.01%	1768
2017 Q2	$5.12K	Hold	170	–	–	﹤0.01%	1882
2017 Q1	$6.15K	Buy	+170	New	+$7.49K	﹤0.01%	1529

Other funds holding FPRX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's FPRX Position: Q3 2018 in Review

Federation des caisses Desjardins du Quebec sold out of Five Prime Therapeutics, Inc. (FPRX) in Q3 2018, closing a stake of 170 shares — an estimated $2.69K sold.

Federation des caisses Desjardins du Quebec first reported a position in FPRX in Q1 2017 and held it in 6 quarters. The position peaked at $6.96K in Q3 2017. 114 funds tracked by Wall St. Rank hold FPRX as of Q3 2018.

Federation des caisses Desjardins du Quebec reported no remaining Five Prime Therapeutics, Inc. position as of Q3 2018 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 170 Five Prime Therapeutics, Inc. shares in Q3 2018, an estimated $2.69K.
Federation des caisses Desjardins du Quebec first reported a position in Five Prime Therapeutics, Inc. in Q1 2017 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Five Prime Therapeutics, Inc. position peaked at $6.96K in Q3 2017.
114 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q3 2018.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q3 2018, filed 30 Aug 2024.